-
2 COVID-19 tests accurately diagnose variant cases in study
Amid questions of accuracy, two rapid antigen COVID-19 tests correctly diagnosed most infections among nearly 800 people experiencing symptoms, researchers found. -
In a surprise discovery, common lab molecule found to have anticancer properties
In a study published in the Proceedings of the National Academy of Sciences, researchers at Chapel Hill, N.C.-based UNC School of Medicine discovered that a molecule commonly used to label DNA triggers a cellular process that is fatal to cancer cells. -
Labcorp acquires outreach services from RWJBarnabas
Labcorp closed its acquisition of West Orange, N.J.-based RWJBarnabas Health's outreach lab business. -
Mako Medical Labs ranked as Inc. 5000 fastest growing company
Reference lab Mako Medical Laboratories was named among Inc. 5000's list of the fastest growing private companies in the U.S. -
ACLA warns low payment rates may hinder monkeypox testing
Trade group American Clinical Laboratory Association warned CMS that "inadequate payment rate[s]" for monkeypox testing may limit patient access. -
The lab industry is ready for monkeypox, says Quest exec
The World Health Organization declared monkeypox a global emergency July 23, and the U.S. issued a similar declaration Aug. 4. More than 14,000 cases have been confirmed in the U.S. as of Aug. 18, according to CDC data. -
Quest launches hepatitis C panel to close maternal healthcare gaps
Quest Diagnostics launched an obstetrics test panel for screening pregnant people for hepatitis C. -
OneSmartLaboratory partners with cybersecurity firm
Richardson, Texas-based management and automation services lab OneSmartLaboratory is partnering with cybersecurity firm Intrusion, Inc., to protect the lab's client operations and connectivity. -
Qiagen launches world-1st test that IDs monkeypox over viruses with similar symptoms
Molecular diagnostics company Qiagen launched the first syndromic test that differentiates between monkeypox and five other viruses with similar symptoms. -
Mako Medical Labs launches phlebotomy training program
Raleigh, N.C.-based national reference lab Mako Medical Laboratories was accredited as an American Society of Phlebotomy Technicians training school. -
Labcorp partners with BD for flow cytometry cancer diagnostics
Labcorp is partnering with BD to develop flow cytometry-based companion diagnostics for diseases including cancer. -
Lab equipment maker recalls 4.1M viral tubes, swabs
Chinese manufacturer Haimen Shengbang Laboratory Equipment recalled 4.1 million viral transport media containers and swabs, the FDA said Aug. 9. -
Sparrow Health testing in-house for monkeypox
Lansing, Mich.-based Sparrow Health is using a new in-house system at its lab in Lansing to test for monkeypox, the Detroit Free Press reported Aug. 8. -
BD to collaborate with Labcorp on cytometry-based companion diagnostics
Medical technology company Becton, Dickinson and Co. is partnering with life sciences company Labcorp to develop cytometry-based companion diagnostics that can be used to match patients with treatments. -
Provista Diagnostics launches 2 contracts for monkeypox testing
Provista Diagnostics, a lab owned by diagnostics company Todos Medical, is entering into two contracts for PCR monkeypox testing. -
Quest, Labcorp techs refusing to draw blood from monkeypox patients
Technicians at Quest Diagnostics and Labcorp have been refusing to draw blood from people who might have monkeypox, CNN reported Aug. 4. -
Class I recall issued on North American Diagnostics rapid COVID-19 test
North American Diagnostics recalled a series of oral COVID-19 rapid antigen test kits, the FDA said Aug. 1. -
New kidney disease lab test formula reclassifies 14-28% of Black patients into more severe disease stage
Removing a race modifier from a standard kidney disease diagnosis formula could reduce healthcare disparities, according to a study from researchers at the University of Texas Southwestern Medical Center and Parkland Health, both based in Dallas. -
Blood test tube shortage could reduce wasteful testing
The COVID-19 pandemic introduced a shortage of blue top blood test tubes, and the experience could reduce wasteful testing even after supply chain issues are rectified. -
Layoffs hit labs as COVID-19 testing dwindles
As at-home COVID-19 tests rise in popularity, U.S. laboratories are slimming their workforce and decreasing their capacity for processing PCR tests, The Wall Street Journal reported July 24.
Page 3 of 50